Syed Khalid Ali | CSO
Panacea Biotech

Syed Khalid Ali, CSO, Panacea Biotech

Dr Khalid is a medical scientist with expertise in vaccinology and infectious diseases. He is the Chief Scientific Officer at Panacea Biotec, one of the leading vaccine manufacturers from India. Dr Khalid is responsible for overall development of vaccines and biologicals at Panace. Several candidates are under development at various stages of development at Panacea, including a Broadly Protective Beta Corona Virus Vaccine. Prior to Panacea, Dr Khalid was Director Clinical R&D at Hilleman Laboratories, he has also worked as a scientist at the International Vaccine Institute in Seoul South Korea. Dr Khalid has studied medicine in India, followed by graduate education from the University of Texas at San Antonio. He has worked in academic, non-profit and commercial entities. He has authored several publications, patents and received several grants from major funding agencies like EDCTP, BMGF, H2020 and CEPI. Dr Khalid has collaborated with and worked in several countries across Asia, Africa, and Europe. Dr Khalid is passionate about promoting health for all by reducing inequity in vaccine access.


Day 3 - Thursday 4th April @ 11:30

The development of multi-epitope, nanoparticle-based vaccine candidates that could provide broad protection against SARS-CoV-2 variants and other Betacoronaviruses

last published: 26/Feb/24 13:16 GMT

back to speakers